Amantadine for multiple sclerosis-related fatigue: a systematic review and meta-analysis of randomized controlled trials
{{output}}
Background: Fatigue affects up to 95% of individuals with multiple sclerosis (MS), significantly impairing daily functioning. Management is multidisciplinary, and although amantadine lacks U.S. FDA approval for this indication, i... ...
